Article

Peripartum myocardial ischemia: a review of Canadian deliveries from 1970 to 1998.

Department of Anesthesia, University of Calgary, Calgary, Canada.
American journal of obstetrics and gynecology (Impact Factor: 3.97). 05/2006; 194(4):1027-33.
Source: PubMed

ABSTRACT The purpose of this study was to evaluate the incidence of peripartum myocardial ischemia in Canada.
We identified the cohort of women who were admitted to Canadian hospitals for delivery between 1970 and 1998 to calculate the incidence rate and to evaluate potential risk factors.
One hundred fourteen of 10,032,375 women delivered in Canadian hospitals between 1970 and 1998 had peripartum myocardial ischemia recorded as a discharge diagnosis. The overall crude incidence rate was 1.1 (95% confidence interval 0.93, 1.37) women with peripartum myocardial ischemia per 100,000 women delivering per year as noted in the Canadian Hospital Morbidity database. Rates did not increase over time but increased with maternal age. Identified risk factors were diabetes mellitus, hyperlipidemia, and chronic heart disease. The case fatality rate among women with the disease was 1.8%.
The incidence of peripartum myocardial ischemia did not increase between 1970 and 1998 in Canada, despite an aging cohort with more prevalent medical comorbidities. Maternal mortality from this event is lower than previously described.

0 Bookmarks
 · 
46 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acute myocardial infarction (AMI) is a rare but often catastrophic event during pregnancy, delivery or puerperium, leading to a high mortality rate. It has different pathogenic mechanisms, such as atherosclerosis, vasospasm, thrombosis and coronary dissection. Although MI has been reported in pregnant women at all stages of pregnancy and postpartum, it occurs more commonly in the third trimester and most commonly involves the anterior wall. Evidence suggests that pregnancy itself is an independent risk factor for MI, conferring a three- to four-fold higher risk than that of nonpregnant women matched for age, possibly due to the unique physiological changes required to meet the demands of a growing foetus. We report a case of a 27-year-old woman with familial hyperlipidaemia presenting with myocardial infarction six days after caesarean delivery, secondary to severe left main coronary stenosis (LMCA), who was treated with emergency coronary artery bypass grafting (CABG).
    Cardiovascular journal of Africa. 06/2013; 24(4):e13-6.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acute myocardial infarction (AMI) is a rare, but possibly catastrophic event during pregnancy, delivery, or puerperium, leading to a high mortality rate. It has different pathogenic mechanisms, such as atherosclerosis, vasospasm, thrombosis, and coronary dissection. Although MI has been reported in pregnant women at all stages of pregnancy and postpartum, it occurs more commonly in the third trimester. Pregnancy-associated MI most commonly involves the anterior wall. Pregnancy itself is an independent risk factor for MI, conferring a fourfold higher risk than that of nonpregnant women matched for age. We report the case of a 27-year-old primigravida at 30 weeks' gestation presenting with anterior MI, secondary to severe stenosis of the left anterior descending coronary artery, treated with emergency percutaneous coronary intervention.
    Herz 07/2013; · 0.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Myocardial infarction is a very rare complication with a 7% mortality rate, during pregnancy, but the incidence increases with the age of the parturient. Coronary artery dissection is a more and more frequent mechanism. Elevated troponin plasma concentration is a specific diagnostic tool in front of atypical symptoms. In pregnant women suffering from coronary artery disease, treatment must be continued except for antagonists of the renin angiotensin receptors. Antiplatelets agents must be interrupted before C-section or epidural. Fibrinolysis for myocardial infarction is contra-indicated by pregnancy, bare stenting is possible to avoid prolonged treatment with antiplatelet agents
    Le Praticien en Anesthésie Réanimation 09/2013; 17(4):174–179.